| [1] |
van Esch JJA, van Heijst AF, de Haan AFJ, et al. Early-onset preeclampsia is associated with perinatal mortality and severe neonatal morbidity[J]. J Matern Fetal Neonatal Med, 2017, 30(23):2789-2794.
|
| [2] |
中华医学会妇产科学分会妊娠期高血压疾病学组. 妊娠期高血压疾病诊治指南(2015)[J]. 中华妇产科杂志，2015, 50(10):721-728.
|
| [3] |
Askie LM, Duley L, Henderson-Smart DJ, et al. Antiplatelet agents for prevention of pre-eclampsia: a Meta-analysis of individual patient data[J]. Lancet, 2007, 369(9575):1791-1798.
|
| [4] |
Rasmussen A, Ravn P. High frequency of congenital thrombophilia in women with pathological pregnancies?[J]. Acta Obstet Gynecol Scand, 2004, 83(9):808-817.
|
| [5] |
何雪仪，王晨虹. 外周血sFlt-1、PlGF、25-羟基维生素D、D-二聚体、vWF及P-选择素等指标预测子痫前期的价值[J]. 国际妇产科学杂志，2016, 43(3):308-311.
|
| [6] |
Stenczer B, Rigó J Jr, Prohászka Z, et al. Plasma osteopontin concentrations in preeclampsia - is there an association with endothelial injury？[J]. Clin Chem Lab Med, 2010, 48(2):181-187.
|
| [7] |
熊贤海，郑丹. 重度子痫前期患者凝血功能及vWF含量的变化和意义[J]. 江西医药，2016，51(10):1031-1033.
|
| [8] |
Ahmad F, Kannan M, Biswas A, et al. Impact of 789Ala/Ala genotype on quantitative type of von Willebrand disease[J]. Ann Hematol, 2009, 88(5):479-483.
|
| [9] |
Sadler JE. Biochemistry and genetics of von Willebrand factor[J]. Annu Rev Biochem, 1998, 67:395-424.
|
| [10] |
Reininger AJ. VWF attributes: impact on thrombus formation[J]. Thromb Res, 2008, 122(Suppl 4):S9-S13.
|
| [11] |
李雪美，江淼，赵益明. 血管性血友病因子的研究进展[J]. 中国实验血液学杂志，2013, 21(3):801-805.
|
| [12] |
李光第，宋恩，周如丹，等. 血小板膜糖蛋白Ⅰbα、血管性血友病因子表达水平与深静脉血栓进展的相关性[J]. 临床检验杂志，2014，32(10):741-745.
|
| [13] |
柳佳吉，罗志强，来永强，等. 血管性血友病因子在风湿性二尖瓣狭窄合并心房纤颤左心房血栓形成中的作用[J]. 中华胸心血管外科杂志，2015，31(10):612-615.
|
| [14] |
兰淑海，唐淑稳，牛秀敏. 低分子肝素治疗重度子痫前期患者外周血vWF、AT的变化[J]. 中国优生与遗传杂志，2012，20(6):52-55.
|
| [15] |
Goertz L, Schneider SW, Desch A, et al. Heparins that block VEGF-A-mediated von Willebrand factor fiber generation are potent inhibitors of hematogenous but not lymphatic metastasis[J]. Oncotarget, 2016, 7(42):68527-68545.
|
| [16] |
孟红娟，贺漪，周萍，等. 依诺肝素钠对早发型重度子痫前期患者胎盘生长因子、25-羟基维生素D、D-二聚体的影响[J]. 疑难病杂志，2016，15(5):502-505.
|
| [17] |
Deng L, Bremme K, Hansson LO, et al. Plasma levels of von Willebrand factor and fibronectin as markers of persisting endothelial damage in preeclampsia[J]. Obstet Gynecol, 1994, 84(6):941-945.
|
| [18] |
王新兰，余承云．孕妇血清TNF-α浓度与妊娠高血压综合征的相关性分析[J]．放射免疫学杂志，2013，26(5):689-690.
|
| [19] |
Perepu U, Rosenstein L. Maternal thrombocytopenia in pregnancy[J]. Proc Obstet Gynecol, 2013, 3(1):4-9.
|
| [20] |
Zheng Y, Chen J, López JA. Flow-driven assembly of VWF fibres and webs in in vitro microvessels[J]. Nat Commun, 2015, 6:7858.
|
| [21] |
Parra-Cordero M, Bosco C, González J, et al. Immunohistochemical expression of von Willebrand factor in the preeclamptic placenta[J]. J Mol Histol, 2011, 42(5):459-465.
|
| [22] |
李媛，张延丽. 妊娠期高血压疾病胎盘源性vWF与vWF-cp的表达及意义[J/CD]. 中西医结合心血管病电子杂志，2015，3(9):81-83.
|
| [23] |
Stepanian A, Cohen-Moatti M, Sanglier T, et al. Von Willebrand factor and ADAMTS13: a candidate couple for preeclampsia pathophysiology[J]. Arterioscler Thromb Vasc Biol, 2011, 31(7):1703-1709.
|
| [24] |
Sadler JE. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura[J]. Blood, 2008, 112(1):11-18.
|
| [25] |
黄浩梁，李慧，陈娟娟，等. 妊娠期高血压患者血管性血友病因子裂解酶的检测及临床意义[J]. 中国妇幼保健，2014, 29(30):4877-4880.
|
| [26] |
Aref S, Goda H. Increased VWF antigen levels and decreased ADAMTS13 activity in preeclampsia[J]. Hematology, 2013, 18(4):237-241.
|
| [27] |
Roman K, Arzhanova ON, Sergey AS, et al. Endothelial dysfunction in gestational diabetes mellitus [C/OL] // The 8th International DIP Symposium on Diabetes, Hypertension, Metabolic Syndrome & Pregnancy, Berlin, 2015.
|
| [28] |
Flood VH, Schlauderaff AC, Haberichter SL, et al. Crucial role for the VWF A1 domain in binding to type Ⅳ collagen[J]. Blood, 2015, 125(14):2297-2304.
|
| [29] |
Maki M, Kobayashi T, Terao T, et al. Antithrombin therapy for severe preeclampsia: results of a double-blind, randomized, placebo-controlled trial. BI51.017 Study Group[J]. Thromb Haemost, 2000, 84(4):583-590.
|